These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20963355)

  • 61. [Expression of hypoxia-inducible factor-1alpha in middle ear cholesteatoma].
    Liu Y; Cui Y; Yu L; Zhang P
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Jan; 19(1):4-6. PubMed ID: 15830692
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Gerbilline cholesteatoma development Part III. Increased proliferation index of basal keratinocytes of the tympanic membrane and external ear canal.
    Tinling SP; Chole RA
    Otolaryngol Head Neck Surg; 2006 Jul; 135(1):116-23. PubMed ID: 16815195
    [TBL] [Abstract][Full Text] [Related]  

  • 63. EGFR expression in acquired middle ear cholesteatoma in children and adults.
    Alves AL; Pereira CS; Carvalho Mde F; Fregnani JH; Ribeiro FQ
    Eur J Pediatr; 2012 Feb; 171(2):307-10. PubMed ID: 21800041
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Acquired medial external auditory canal stenosis, anterior tympanomeatal angle blunting, and lateralized tympanic membrane: Nosology, diagnosis, and treatment.
    Karkas A; Badidi G; Odinet P; Reynard P; Martin C
    Eur Ann Otorhinolaryngol Head Neck Dis; 2019 Apr; 136(2):93-97. PubMed ID: 30639598
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Expression of Apoptotic vs Antiapoptotic Proteins in Middle Ear Cholesteatoma.
    Chung JH; Lee SH; Park CW; Kim KR; Tae K; Kang SH; Oh YH; Pyo JY
    Otolaryngol Head Neck Surg; 2015 Dec; 153(6):1024-30. PubMed ID: 26124267
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparison of the value of PCNA and Ki-67 as markers of cell proliferation in ameloblastic tumors.
    Bologna-Molina R; Mosqueda-Taylor A; Molina-Frechero N; Mori-Estevez AD; Sánchez-Acuña G
    Med Oral Patol Oral Cir Bucal; 2013 Mar; 18(2):e174-9. PubMed ID: 23229269
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Different production of interleukin-1alpha, interleukin-1beta and interleukin-8 from cholesteatomatous and normal epithelium.
    Chung JW; Yoon TH
    Acta Otolaryngol; 1998 Jun; 118(3):386-91. PubMed ID: 9655214
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A comparison of patterns of disease extension in keratosis obturans and external auditory canal cholesteatoma.
    Shinnabe A; Hara M; Hasegawa M; Matsuzawa S; Kanazawa H; Yoshida N; Iino Y
    Otol Neurotol; 2013 Jan; 34(1):91-4. PubMed ID: 23235551
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Involvement of interleukin-1 in middle ear cholesteatoma.
    Shiwa M; Kojima H; Kamide Y; Moriyama H
    Am J Otolaryngol; 1995; 16(5):319-24. PubMed ID: 7503375
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Expression pattern of the plasminogen activator-plasmin system in human cholesteatoma.
    Schönermark MP; Issing PR; Erbrich BK; Lenarz T
    Ann Otol Rhinol Laryngol; 1999 Mar; 108(3):245-52. PubMed ID: 10086616
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The effect of BMP-2, BMP-4 and BMP-6 on bone destruction of cholesteatoma presence.
    Oger M; Alpay HC; Orhan I; Onalan EE; Yanilmaz M; Sapmaz E
    Am J Otolaryngol; 2013; 34(6):652-7. PubMed ID: 23927997
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Evaluation of proliferative activity in middle ear cholesteatoma using proliferating cell nuclear antigen.
    Shieh TJ; Ho KY; Kuo WR; Chai CY; Lin CS; Juan KH
    Kaohsiung J Med Sci; 1999 Aug; 15(8):468-74. PubMed ID: 10518363
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cholesteatoma in children.
    Hildmann H; Sudhoff H
    Int J Pediatr Otorhinolaryngol; 1999 Oct; 49 Suppl 1():S81-6. PubMed ID: 10577781
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Activation of the EGFR/Akt/NF-κB/cyclinD1 survival signaling pathway in human cholesteatoma epithelium.
    Liu W; Yin T; Ren J; Li L; Xiao Z; Chen X; Xie D
    Eur Arch Otorhinolaryngol; 2014 Feb; 271(2):265-73. PubMed ID: 23463347
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Immunohistochemical detection of Ki-67 and PCNA in canine mammary tumors: relationship to clinical and pathologic variables.
    Peña LL; Nieto AI; Pérez-Alenza D; Cuesta P; Castaño M
    J Vet Diagn Invest; 1998 Jul; 10(3):237-46. PubMed ID: 9683072
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cell shape in the migratory epidermis of the external auditory canal.
    Johnson A; Hawke M
    J Otolaryngol; 1985 Oct; 14(5):273-81. PubMed ID: 4068122
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Expression of a cell-cycle-associated nuclear antigen (MIB 1) in cholesteatoma and auditory meatal skin.
    Sudhoff H; Bujía J; Fisseler-Eckhoff A; Holly A; Schulz-Flake C; Hildmann H
    Laryngoscope; 1995 Nov; 105(11):1227-31. PubMed ID: 7475881
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Expression of bone morphogenetic protein-2 messenger ribonucleic acid in cholesteatoma fibroblasts.
    Schmidt M; Schler G; Gruensfelder P; Hoppe F
    Otol Neurotol; 2002 May; 23(3):267-70. PubMed ID: 11981380
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Possible role of transforming growth factor alpha on the cholesteatoma growth regulation].
    Xu Y; Wu Z; Tao Z; Hua Q; Jin K
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 Jan; 17(1):32-4. PubMed ID: 12725186
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Possible role of interleukin 1 alpha and interleukin 1 beta in the pathogenesis of cholesteatoma of the middle ear.
    Schilling V; Negri B; Bujía J; Schulz P; Kastenbauer E
    Am J Otol; 1992 Jul; 13(4):350-5. PubMed ID: 1384343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.